Pulmonary Drug Delivery Devices Market - Global Forecast 2026-2032

The pulmonary drug delivery devices market is evolving quickly as innovation, regulatory shifts, and clinical priorities intersect. Senior leaders evaluating this sector encounter dynamic challenges that require adaptable strategies for sustained advantage.

Market Snapshot: Pulmonary Drug Delivery Devices Market

The global pulmonary drug delivery devices market is projected to reach USD 85.34 billion by 2032, growing from USD 48.45 billion in 2025 and USD 51.75 billion in 2026, at a CAGR of 8.42%. This growth is propelled by a heightened focus on inhaled therapies, advances in device design, and changing payer expectations centered on both economic efficiency and proven patient outcomes. Senior stakeholders are tracking technological progress, expanding use cases, and recognition of therapeutic value in real-world applications as prominent factors influencing business strategies and market positioning in the coming years.

Scope & Segmentation

Device Types: Covers dry powder inhalers, including capsule-based, multi-dose, and single-dose systems; metered dose inhalers differentiated by propellants; nebulizers across jet, mesh, and ultrasonic segments; nasal sprays using pump actuator or propellant-based technologies; and soft mist inhalers, each targeting specific patient and operational needs.
Therapeutic Areas: Includes allergic rhinitis, asthma, bronchiectasis, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pulmonary arterial hypertension, underscoring broad clinical coverage and device application diversity.
Drug Modalities: Encompasses small molecules, combination therapies from dual to quad regimens, biologics such as monoclonal antibodies, peptides, recombinant proteins, and both inactivated and live attenuated vaccine types, reflecting shifting product development pipelines.
End-User Contexts: Serves general and respiratory-focused clinics, home healthcare settings, hospitals, and specialty centers, highlighting different standards for device usability, patient training requirements, and operational support structures.
Distribution Channels: Consists of offline networks like hospital and retail pharmacies, and digital options including over-the-counter and prescription-based e-commerce, which influence packaging design, logistics, and access patterns regionally.
Geographical Coverage: Includes the Americas, Europe Middle East & Africa (EMEA), and Asia-Pacific, with each region shaped by its regulatory environment, health infrastructure maturity, and economic factors that impact adoption rates and commercialization paths.
Technological Innovations: Involves aerosol generation optimization, improved deposition and delivery control, miniaturized soft-mist and mesh systems, digital adherence tracking, and integration with clinical outcome monitoring platforms to meet evolving patient and practitioner needs.

Key Takeaways: Strategic Shifts and Innovation Drivers

Emerging inhaled biologics and advanced combination therapies require greater attention to device precision, patient usability, and differentiated product design.
Patient-centric engineering now prioritizes both environmental sustainability and digital functionality, driving improved adherence and measurable clinical efficacy.
Regulatory standards increasingly demand in-depth human factors validation, robust quality control, and comprehensive device-drug compatibility assessment, impacting time-to-market and commercialization strategies.
Payers are demanding clearer evidence of cost-effectiveness and clinical value, placing greater pressure on manufacturers to support outcomes-based reporting for improved access and reimbursement.
Shift toward adaptable manufacturing and expanded sourcing has strengthened supply resilience, enabling proactive responses to evolving policy directives and supply chain risks.
Cross-functional collaboration among clinical, technical, and commercial teams is critical for scaling adoption and maximizing the impact of device innovations worldwide.

Tariff Impact: United States 2025 Tariff Measures

Recent U.S. tariffs on imported pulmonary device components and finished products have increased cost complexity within the supply chain. This development is compelling organizations to reconsider sourcing, accelerate automation, and diversify their supplier bases. With greater scrutiny on duty exposure, procurement strategies now include a higher degree of reliance on local suppliers, which is influencing both manufacturing practice and industry collaboration between device manufacturers and drug development partners.

Methodology & Data Sources

This assessment draws on direct interviews with clinicians, engineers, regulatory experts, procurement specialists, and payers, supported by secondary research from technical standards, patent filings, and clinical data. Device evaluation processes included standardized aerosol performance benchmarking and supply chain resilience stress tests, with stakeholder workshops guiding segmentation, data validation, and actionable insight generation.

Why This Report Matters

Clarifies the intersection of clinical, technological, and market forces defining the pulmonary drug delivery devices market and assists leaders in strategic planning.
Equips decision-makers with evidence-based guidance for device selection, partnership evaluation, and digital adoption to support commercial and clinical success.
Provides practical strategies to navigate regulatory scrutiny, secure payer engagement, and address emerging threats to global value chain stability.

Conclusion

Success in the pulmonary drug delivery devices sector demands ongoing alignment of innovation, regulatory compliance, and payer requirements. Use this analysis to inform strategic investment and operational adaptation in a market characterized by opportunity and complexity.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Pulmonary Drug Delivery Devices Market, by Device Type

8.1. Dry Powder Inhaler
8.1.1. Capsule Based
8.1.2. Multi Dose Reservoir
8.1.3. Single Dose Powder Reservoir
8.2. Metered Dose Inhaler
8.2.1. CFC Propellant
8.2.2. HFA Propellant
8.3. Nasal Spray
8.3.1. Propellant Based
8.3.2. Pump Actuator
8.4. Nebulizer
8.4.1. Jet Nebulizer
8.4.2. Mesh Nebulizer
8.4.3. Ultrasonic Nebulizer
8.5. Soft Mist Inhaler

9. Pulmonary Drug Delivery Devices Market, by Therapy

9.1. Allergic Rhinitis
9.2. Asthma
9.3. Bronchiectasis
9.4. COPD
9.5. Cystic Fibrosis
9.6. Pulmonary Arterial Hypertension

10. Pulmonary Drug Delivery Devices Market, by Drug Type

10.1. Biologics
10.1.1. Monoclonal Antibody
10.1.2. Peptide
10.1.3. Recombinant Proteins
10.2. Combination Therapy
10.2.1. Dual Combination
10.2.2. Quad Combination
10.2.3. Triple Combination
10.3. Small Molecule
10.4. Vaccines
10.4.1. Inactivated
10.4.2. Live Attenuated

11. Pulmonary Drug Delivery Devices Market, by End User

11.1. Clinics
11.1.1. General Clinics
11.1.2. Respiratory Clinics
11.2. Home Healthcare
11.3. Hospitals
11.4. Specialty Centers

12. Pulmonary Drug Delivery Devices Market, by Distribution Channel

12.1. Offline Pharmacies
12.1.1. Hospital Pharmacies
12.1.2. Retail Pharmacies
12.2. Online Pharmacies
12.2.1. OTC Ecommerce
12.2.2. Prescription Ecommerce

13. Pulmonary Drug Delivery Devices Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Pulmonary Drug Delivery Devices Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Pulmonary Drug Delivery Devices Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Pulmonary Drug Delivery Devices Market
17. China Pulmonary Drug Delivery Devices Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. 3M Company
18.6. Aerogen Limited
18.7. AptarGroup, Inc.
18.8. AstraZeneca PLC
18.9. Boehringer Ingelheim International GmbH
18.10. Chiesi Farmaceutici S.p.A.
18.11. Cipla Limited
18.12. F. Hoffmann-La Roche Ltd.
18.13. GlaxoSmithKline plc
18.14. Koninklijke Philips N.V.
18.15. Merck & Co., Inc.
18.16. Novartis AG
18.17. Omron Corporation
18.18. PARI GmbH
18.19. Teva Pharmaceutical Industries Ltd.

List of Figures

FIGURE 1. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CAPSULE BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CAPSULE BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CAPSULE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MULTI DOSE RESERVOIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MULTI DOSE RESERVOIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MULTI DOSE RESERVOIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SINGLE DOSE POWDER RESERVOIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SINGLE DOSE POWDER RESERVOIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SINGLE DOSE POWDER RESERVOIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CFC PROPELLANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CFC PROPELLANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CFC PROPELLANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HFA PROPELLANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HFA PROPELLANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HFA PROPELLANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PROPELLANT BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PROPELLANT BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PROPELLANT BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PUMP ACTUATOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PUMP ACTUATOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PUMP ACTUATOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY JET NEBULIZER, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY JET NEBULIZER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY JET NEBULIZER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SOFT MIST INHALER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SOFT MIST INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ALLERGIC RHINITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ALLERGIC RHINITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BRONCHIECTASIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BRONCHIECTASIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BRONCHIECTASIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MONOCLONAL ANTIBODY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MONOCLONAL ANTIBODY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PEPTIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PEPTIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PEPTIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DUAL COMBINATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DUAL COMBINATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DUAL COMBINATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY QUAD COMBINATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY QUAD COMBINATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY QUAD COMBINATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY TRIPLE COMBINATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY TRIPLE COMBINATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY TRIPLE COMBINATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY INACTIVATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY INACTIVATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY LIVE ATTENUATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY LIVE ATTENUATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GENERAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GENERAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OTC ECOMMERCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OTC ECOMMERCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OTC ECOMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRESCRIPTION ECOMMERCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRESCRIPTION ECOMMERCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRESCRIPTION ECOMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 154. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 155. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2032 (USD MILLION)
TABLE 156. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2032 (USD MILLION)
TABLE 157. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 158. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2032 (USD MILLION)
TABLE 159. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 160. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 161. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 162. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2032 (USD MILLION)
TABLE 163. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 164. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 166. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 167. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 168. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2032 (USD MILLION)
TABLE 173. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 174. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2032 (USD MILLION)
TABLE 175. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 176. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 177. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 178. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2032 (USD MILLION)
TABLE 179. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 180. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 182. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 183. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 184. NORTH AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2032 (USD MILLION)
TABLE 189. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 190. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2032 (USD MILLION)
TABLE 191. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 192. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 193. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 194. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2032 (USD MILLION)
TABLE 195. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 196. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 198. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 199. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 200. LATIN AMERICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2032 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2032 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2032 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2032 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 217. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 218. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 219. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2032 (USD MILLION)
TABLE 220. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2032 (USD MILLION)
TABLE 221. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 222. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2032 (USD MILLION)
TABLE 223. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 224. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 225. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 226. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2032 (USD MILLION)
TABLE 227. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 228. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 230. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 231. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 232. EUROPE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 235. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2032 (USD MILLION)
TABLE 236. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2032 (USD MILLION)
TABLE 237. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 238. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2032 (USD MILLION)
TABLE 239. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 240. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 241. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 242. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2032 (USD MILLION)
TABLE 243. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 244. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 246. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 247. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 248. MIDDLE EAST PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 249. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 251. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2032 (USD MILLION)
TABLE 252. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2032 (USD MILLION)
TABLE 253. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 254. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2032 (USD MILLION)
TABLE 255. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 256. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 257. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 258. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2032 (USD MILLION)
TABLE 259. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 260. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 262. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 263. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 264. AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 265. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 266. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 267. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2032 (USD MILLION)
TABLE 268. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2032 (USD MILLION)
TABLE 269. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 270. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2032 (USD MILLION)
TABLE 271. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 272. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 273. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 274. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2032 (USD MILLION)
TABLE 275. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 276. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 277. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 278. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 279. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 280. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 281. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 282. ASEAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 283. ASEAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 284. ASEAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2032 (USD MILLION)
TABLE 285. ASEAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2032 (USD MILLION)
TABLE 286. ASEAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 287. ASEAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2032 (USD MILLION)
TABLE 288. ASEAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 289. ASEAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 290. ASEAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032

Companies Mentioned

The key companies profiled in this Pulmonary Drug Delivery Devices market report include:

3M Company
Aerogen Limited
AptarGroup, Inc.
AstraZeneca PLC
Boehringer Ingelheim International GmbH
Chiesi Farmaceutici S.p.A.
Cipla Limited
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Koninklijke Philips N.V.
Merck & Co., Inc.
Novartis AG
Omron Corporation
PARI GmbH
Teva Pharmaceutical Industries Ltd.

Table Information

Report Attribute	Details
No. of Pages	182
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 51.75 Billion
Forecasted Market Value ( USD ) by 2032	$ 85.34 Billion
Compound Annual Growth Rate	8.4%
Regions Covered	Global
No. of Companies Mentioned	16

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3501EUR$3,939USD£3,033GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3777EUR$4,249USD£3,272GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5119EUR$5,759USD£4,434GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6194EUR$6,969USD£5,366GBP

Market Snapshot: Pulmonary Drug Delivery Devices Market

Scope & Segmentation

Key Takeaways: Strategic Shifts and Innovation Drivers

Tariff Impact: United States 2025 Tariff Measures

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Inhalation Pulmonary Drug Delivery Devices Market - Global Forecast 2026-2032

Aerosol Drug Delivery Devices Market Report 2025

Pulmonary Drug Delivery Systems Market

Pulmonary Drug Delivery Devices Market Report 2025

Pulmonary Drugs Market - Global Forecast 2026-2032